The Pet Supplement ODF Opportunity: Why Oral Dissolving Films Are Winning in Animal Health

The Pet Supplement ODF Opportunity: Why Oral Dissolving Films Are Winning in Animal Health

Pet supplements are one of the fastest-growing segments in animal health. Driven by the humanization of pets—owners applying the same standards of preventive care to their animals that they apply to themselves—the market for functional pet products has expanded from basic multivitamins into targeted formats addressing joint health, anxiety, dental care, and cognition. The format of delivery is becoming as important as the active ingredients inside.

Oral dissolving films (ODFs) are emerging as a compelling format in this space—and for good reason. This article examines why ODF works specifically for pet applications, the manufacturing requirements that define the opportunity, and how brands can evaluate their options.

Why ODF Works for Pet Supplements

Traditional pet supplement formats—chews, powders, tablets—each carry limitations. Chews rely on palatability formulation that varies across species and individual animals. Powders mixed into food are inconsistently consumed. Tablets can be difficult to administer without the animal spitting them out or hiding them.

ODF addresses these challenges directly:

  • No swallowing difficulty. The film dissolves on contact with oral mucosa. For dogs, cats, and small animals that resist tablets, this eliminates the primary administration barrier.
  • Fast absorption. Buccal and sublingual absorption allows actives to enter the bloodstream without depending on GI tract conditions, which vary significantly between individual animals.
  • Accurate dosing. Each film strip is manufactured to a precise dose. Unlike soft chews where density and active distribution can vary by batch, ODF dosing is defined by the coating process itself.
  • Palatability by design. Flavoring agents—chicken, beef, fish-derived flavor compounds—can be incorporated directly into the film matrix without compromising the delivery mechanism.
  • Compact and easy to administer. A thin film strip is easier to handle than a tablet and more tamper-evident than a loose chew.

These advantages translate directly into better adherence—which, in pet health as in human health, is the single biggest determinant of supplement efficacy.

The Pet Supplement Market Context

The trend driving this opportunity is well-documented: pet owners increasingly treat companion animals as family members, extending to their healthcare choices the same quality standards applied to human products. This creates direct pull for premium supplement formats. When a consumer is already purchasing pharmaceutical-grade supplements for themselves in ODF format, they are predisposed to purchase the same format for their pet.

Certified contract manufacturers operating under frameworks such as FDA, BRC, FSSC22000, ISO22000, NSF, and ISO9001 are already producing established pet ODF product lines:

  • Calm ODF (anxiety and stress support)
  • Oral Health ODF (dental and gum care)
  • Composite Vitamin ODF (multi-nutrient support)

The existence of GMP-equivalent contract manufacturers already running these formats confirms that pet ODF is not a theoretical category—it is in active commercial production today.

The Manufacturing Challenge

Producing ODF for pet supplements is technically identical to producing ODF for human nutraceuticals. The core process is the same:

  1. Prepare an aqueous or solvent-based slurry containing the active ingredient, polymer matrix (typically HPMC or PVA), plasticizer, and any flavoring agents.
  2. Apply the slurry to a release liner via a precision coating head.
  3. Dry the coated film through a controlled drying tunnel.
  4. Detect film thickness inline and slit to target width.
  5. Cut, seal, and package individual film strips.

The challenge for brands entering this space is that each step requires precise process control. Film thickness variation directly affects dose uniformity. Drying profile affects residual solvent, texture, and dissolution rate. Flavoring agents must be selected for heat stability during the drying phase.

GMP-compliant production also requires:

  • Documented batch records for every production run
  • Validated cleaning procedures between products (especially relevant for multi-species facilities)
  • Inline quality controls: film thickness detection, weight uniformity checks
  • Traceability: lot-level tracking from raw material receipt to finished product release

These requirements are non-negotiable for brands selling through any regulated retail, e-commerce, or export channel.

GMP Equipment Requirements for Pet ODF Production

The equipment used for pharmaceutical-grade human ODF production is the same equipment appropriate for pet supplement ODF. There is no separate "pet-grade" category—either a machine meets GMP standards or it does not.

Huanghai's MJ Pro Series coating machines are designed for exactly this requirement. The MJ150-L lab-scale coating machine supports:

  • Food-grade production: Yes
  • Health supplement-grade production: Yes
  • Pharmaceutical-grade production: Yes
  • GMP compliant: Yes (cGMP)
  • Output capacity: 8,000–10,000 films/hour (15mm film spec basis)
  • Coating technology: Patented stripe precision coating (Patent CN117323228A)
  • Drying system: Patented hot-air tunnel drying (Patent CN201668734U), with progressive temperature profiling and 20–30% higher drying efficiency than plate-based systems
  • Inline film thickness detection: Yes
  • Key functions: Base film unwinding, film loading, patented stripe coating, drying, film thickness detection, film rewinding, online slitting
  • Major electrical components: Imported Siemens PLC, sensors, electrical systems
  • Price: Contact us for pricing

For brands at the R&D stage that are not yet ready for the MJ150-L investment, the BY-300A Lab-Scale Film Coater provides an entry point for formulation development and palatability testing before scale-up.

The full-scale MJ150 coating machine outputs films per hour across three platform generations: The MJ150 platform is offered in three generations: Generation I (130 mm casting roll, 3–4 stripes, 20,000 films/hour — default factory demo configuration), Generation II (400 mm casting roll, 9–12 stripes, 60,000 films/hour), and Generation III (400 mm × 2 Twin Tunnel, 18–24 stripes, 120,000 films/hour). The generation must be specified at the order stage — generation upgrades are not field-retrofit operations. for brands operating commercial production lines.

Equipment also extends to downstream processing. The MJF180 Cutting and Packaging Machine handles film slitting, cutting, heat sealing, one-object-one-code printing, and rejection detection at 11,900 films/hour. For lower-volume lines, the EZ320 Manual Cutting Machine processes 9,000 films/hour. Contact us for pricing on all models.

Contract Manufacturing as an Alternative to In-House Equipment

Brands that need ODF products manufactured—rather than their own production line—can route the project through a certified contract manufacturer. Established pet ODF capabilities currently in commercial production include Calm ODF, Oral Health ODF, and Composite Vitamin ODF, produced under pharmaceutical-grade processes (FDA / BRC / FSSC22000 / NSF / ISO frameworks).

For supplement brands that want to enter the pet ODF category without investing in production equipment, contract manufacturing offers a validated manufacturing pathway with shorter time-to-market.

Huanghai coordinates ODF contract manufacturing inquiries on behalf of brand owners. To submit your project requirements—target formulation, dosage, volume, certifications needed—use the dedicated intake page:

Submit an ODF Contract Manufacturing Inquiry →

How to Get Started

The practical decision tree for a pet supplement brand considering ODF looks like this:

  • If you have an existing formulation but no ODF experience: Start with the BY-300A for internal R&D and formulation development. Palatability testing with your target species (dog, cat, etc.) can begin at this stage with bench-scale film batches.
  • If you need validated production now but lack in-house manufacturing capability: Engage a certified contract manufacturer with existing pet ODF formulations and GMP-certified production capacity. Submit your requirements via our ODF Contract Manufacturing intake page.
  • If you plan to build in-house ODF production for pet supplements at scale: The MJ150-L is the appropriate pilot-to-commercial platform. Huanghai provides on-site installation by certified engineers and remote technical support for 10 hours per business day post-installation.
  • If you are a contract manufacturer adding pet ODF to your service menu: The full MJ150 production line (coating + MJF180 cutting and packaging) provides commercial-grade throughput under cGMP conditions.

Contact us for pricing on all ODF equipment →

Conclusion

The pet supplement ODF opportunity is real, commercially active, and under-served by most current supplement manufacturers. The same format advantages that drive ODF adoption in human health—fast dissolution, accurate dosing, no swallowing difficulty, palatability control—apply with equal or greater force in animal health. The manufacturing requirements are identical to human nutraceutical ODF, which means the equipment and expertise already exist.

For brands ready to enter this category—whether through contract manufacturing or in-house production—Huanghai's equipment ecosystem and our coordinated contract-manufacturing intake provide a clear, technically grounded starting point.

Contact Huanghai to discuss pet ODF equipment and production options →

Verify our compliance credentials. Shanghai Huanghai Pharmaceutical Instruments holds FDA / GMP / ISO certifications across our pharma testing and ODF manufacturing equipment lines. View our Certifications →

Back to blog

Contact us